PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in Aubagne, France declares total shares and voting rights as of November 30, 2024 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital as per regulatory requirements Voting Rights Shares Sartorius Stedim Biotech AMF Regulations French Regulatory News
BRIEF published on 11/04/2024 at 10:16, 1 year 11 months ago Sartorius Stedim Biotech Statement on Shares and Voting Rights Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 11/04/2024 at 10:11, 1 year 11 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,567,396 Voting Rights Shares Sartorius Stedim Biotech Issued Capital French Regulatory News
BRIEF published on 10/17/2024 at 07:07, 2 years ago Sartorius Stedim Biotech: Unaudited results for the first nine months of 2024 Financial Results Sartorius Stedim Biotech Outlook 2024 Advanced Therapies Turnover
PRESS RELEASE published on 10/17/2024 at 07:02, 2 years ago Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 Sartorius Stedim Biotech posts unaudited 9-month results for 2024, confirming outlook. Sales revenue 2,029 million euros, EBITDA 565 million euros, strong consumables demand EBITDA Sartorius Stedim Biotech Sales Revenue 9-month Figures Consumables
BRIEF published on 10/01/2024 at 11:19, 2 years ago Statement on the number of shares and voting rights at Sartorius Stedim Biotech Share Capital Voting Rights Actions Sartorius Stedim Biotech Regulatory
PRESS RELEASE published on 10/01/2024 at 11:15, 2 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Press release regarding the declaration of the number of shares and voting rights of Sartorius Stedim Biotech S.A. in France Voting Rights Capital Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 10/01/2024 at 11:14, 2 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights making up the issued capital. Details according to French regulations Voting Rights Shares French Regulations Sartorius Stedim Biotech Issued Capital
BRIEF published on 09/03/2024 at 10:20, 2 years 1 month ago Sartorius Stedim Biotech SA Announces Number of Shares and Voting Rights Voting Rights Shares Issued Capital Regulatory News Sartorius Stedim
Published on 10/30/2026 at 23:35, 1 day 3 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 3 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 8 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 11 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 10 hours 49 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 4 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 8 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 4 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 15 hours ago Capital increase through exercise of subscription rights
